<DOC>
	<DOCNO>NCT01506856</DOCNO>
	<brief_summary>The purpose study : Phase A : To confirm feasibility paclitaxel administer intravenous ( IV ) infusion weekly plus concurrent carboplatin administer intraperitoneal ( IP ) injection every 3 week ( dd-TCip therapy ) . Phase B : To compare efficacy safety follow two treatment regimen first-line chemotherapy woman epithelial ovarian , Fallopian tube primary peritoneal cancer .</brief_summary>
	<brief_title>Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial</brief_title>
	<detailed_description>This randomize , multicenter international study . Patient stratify accord Residual tumor diameter ( [ 0cm ( No residual ) ] vs. [ 0cm＜residual＜1cm ] vs. [ 1cm &lt; residual &lt; 2cm ] vs. [ &gt; 2 cm ] ) , FIGO stage ( StageII vs. III vs. IV ) institution . Patient randomize one treatment arm describe . RegimenI ( Standard treatment : dd-TCiv therapy ) : Paclitaxel administer IV infusion weekly plus concurrent carboplatin administer IV infusion every 3 week RegimenII ( Study treatment : dd-TCip therapy ) : Paclitaxel administer IV infusion weekly plus concurrent carboplatin administer IP injection every 3 week The 3-week period ( 21 day ) 1 cycle . Protocol treatment basically comprise 6 cycle . IDS allow perform 3 , 4 5 cycle protocol treatment . In case , protocol treatment must restart within 8 week IDS . If IDS perform , patient receive 3 additional cycle protocol treatment IDS . If interval debulking surgery ( IDS ) perform 3 , 4 5 cycle , patient receive 3 additional cycle protocol treatment . A total 6 8 cycle repeat . The analysis efficacy perform randomized subject accordance intention-to-treat ( ITT ) principle . In order ass robustness result , analyse do use randomized subject satisfy eligibility criterion . The analysis safety perform subject receive least one dose study treatment .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1 . Patients assume stageII−IV epithelial ovarian , fallopian tube , primary peritoneal cancer presurgery diagnosis 2 . Patients schedule undergo laparotomy *Both optimal suboptimal patient eligible study ( Suboptimal patient , well undergo exploratory laparotomy , eligible . ) 3 . ECOG Performance Status : 02 4 . Patients provide consent placement IP port system , randomize Regimen II ( Study treatment : ddTCip therapy ) 5 . Patients expect receive first protocol treatment within 8 week comprehensive stag surgery 6 . Lab data clinical examination : Data within 28 day schedule date surgery Neutrophil count ≧ 1,500 /mm3 Platelet count ≧ 100,000 /mm3 AST ( GOT ) ≦ 100 IU/L ALT ( GPT ) ≦ 100 IU/L Total bilirubin &lt; 1.5 mg/dL Serum Creatinine &lt; 1.5 mg/dL Electrocardiogram ( ECG ) : Patients normal ECG , Asymptomatic patient abnormal ECGs require medical intervention Neuropathy ( Both motor sensory ) ≦ Grade1 ( CTCAE Version 4.0 ) 7 . Patients expect survive long 3 month start date protocol treatment 8 . Patients age 20 year old time tentative registration ( upper age limit ) 9 . Patients provide write informed consent participation trial 1 . Patients assume borderline malignancy ovary , fallopian tube , primary peritoneal cancer 2 . Patients receive previous chemotherapy radiation therapy treat current disease 3 . Patients synchronous malignancy progressionfree less 5 year metachronous malignancy ( Patients basal squamous cell carcinoma skin , well carcinoma situ , intramucosal carcinoma cure local treatment , eligible study ) 4 . Patients serious medical complication , serious heart disease , cerebrovascular accident , uncontrolled diabetes mellitus , uncontrolled hypertension , pulmonary fibrosis , interstitial pneumonitis , active bleeding , active gastrointestinal ulcer , serious neurological disorder 5 . Patients hypersensitivity reaction polyoxyethylated hydrogenated castor oil 6 . Patients pleural effusion require continuous drainage 7 . Patients active infection require antibiotic 8 . Patients pregnant , nurse childbearing potential 9 . Patients evidence upon physical examination brain tumor brain metastases 10 . Patients completion study and/or followup deem inappropriate reason 11 . Patients signs/symptoms interstitial pneumonia</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Epithelial ovarian cancer</keyword>
	<keyword>Fallopian tube cancer</keyword>
	<keyword>peritoneal cancer</keyword>
	<keyword>intraperitoneal therapy</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>